Core Viewpoint - The company, Shangrong Medical, has successfully returned 150 million RMB of temporarily used funds to its fundraising account, ensuring compliance with regulations and maintaining the integrity of its fundraising purposes [1][2]. Trading Information Summary - On October 22, 2025, Shangrong Medical's stock closed at 4.13 RMB, with an increase of 0.73% and a turnover rate of 3.83%. The trading volume was 234,100 shares, resulting in a transaction amount of 96.37 million RMB [1]. - On the same day, the main funds experienced a net outflow of 15.26 million RMB, while retail investors saw a net inflow of 13.30 million RMB [2]. Company Announcement Summary - On January 10, 2025, the company held a board meeting where it approved the temporary use of up to 150 million RMB from the proceeds of a public convertible bond issuance to supplement working capital for a period not exceeding twelve months [1]. - As of October 21, 2025, the company has fully returned the 150 million RMB to the fundraising account, and the return was in accordance with relevant regulations [1][2].
股市必读:尚荣医疗(002551)10月22日主力资金净流出1525.99万元